Advancing the global public health agenda for NAFLD: a consensus statement

JV Lazarus, HE Mark, QM Anstee, JP Arab… - Nature Reviews …, 2022 - nature.com
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects
approximately one-quarter of the global adult population, causing a substantial burden of ill …

The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri… - The Lancet, 2022 - thelancet.com
Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update

CPG Panel, A Berzigotti, E Tsochatzis, J Boursier… - Journal of …, 2021 - Elsevier
Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …

AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review

MT Long, M Noureddin, JK Lim - Gastroenterology, 2022 - Elsevier
Description Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading
etiology for chronic liver disease, affecting> 25% of the US and global populations. Up to 1 …

Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based …

H Jarvis, D Craig, R Barker, G Spiers, D Stow… - PLoS …, 2020 - journals.plos.org
Background Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver
disease worldwide. Many individuals have risk factors associated with NAFLD, but the …

[PDF][PDF] Population screening for liver fibrosis: toward early diagnosis and intervention for chronic liver diseases

P Ginès, L Castera, F Lammert, I Graupera… - …, 2022 - Wiley Online Library
Cirrhosis, highly prevalent worldwide, develops after years of hepatic inflammation
triggering progressive fibrosis. Currently, the main etiologies of cirrhosis are non‐alcoholic …

Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties

AM Allen, JV Lazarus, ZM Younossi - Journal of hepatology, 2023 - Elsevier
Left unaddressed, non-alcoholic fatty liver disease (NAFLD) will continue to have substantial
health, economic and social implications. To address the challenge, a paradigm shift is …

Management of non-alcoholic fatty liver disease

ML Petroni, L Brodosi, E Bugianesi, G Marchesini - Bmj, 2021 - bmj.com
Non-alcoholic fatty liver disease is a very common medical condition, driven by a
combination of genetic and lifestyle factors, ultimately producing a severe chronic liver …

Defining comprehensive models of care for NAFLD

JV Lazarus, QM Anstee, H Hagström, K Cusi… - Nature reviews …, 2021 - nature.com
Non-alcoholic fatty liver disease (NAFLD) is now the leading cause of chronic liver disease
globally. Despite the increased demand placed on health-care systems, little attention has …

Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management

T Marjot, A Moolla, JF Cobbold, L Hodson… - Endocrine …, 2020 - academic.oup.com
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of disease, extending from simple
steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It …